259 related articles for article (PubMed ID: 25089033)
1. Malassezia growth on peritumoral skin after routine methyl-5-aminolevulinate photodynamic therapy for actinic keratosis and nonmelanoma skin cancer.
Gilaberte Y; Aspiroz C; Alejandre C; Rezusta A
Actas Dermosifiliogr; 2015; 106(1):70-1. PubMed ID: 25089033
[No Abstract] [Full Text] [Related]
2. [Studies of methyl aminolevulinate photodynamic therapy for actinic keratosis].
Fernández-Guarino M; Harto A; Jaén P
Actas Dermosifiliogr; 2010 May; 101(4):315-22. PubMed ID: 20487686
[TBL] [Abstract][Full Text] [Related]
3. Topical photodynamic therapy with methyl aminolevulinate may be an alternative therapeutic option for the recalcitrant Malassezia folliculitis.
Lee JW; Lee HI; Kim MN; Kim BJ; Chun YJ; Kim D
Int J Dermatol; 2011 Apr; 50(4):488-90. PubMed ID: 21413966
[No Abstract] [Full Text] [Related]
4. Methyl aminolevulinate photodynamic therapy for actinic keratosis does not affect peripheral regulatory T-cell level or function.
Reginato E; Gruber-Wackernagel A; Wolf P
Photodermatol Photoimmunol Photomed; 2015 Sep; 31(5):274-8. PubMed ID: 25847118
[No Abstract] [Full Text] [Related]
5. Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers.
Ortiz-Policarpio B; Lui H
Skin Therapy Lett; 2009; 14(6):1-3. PubMed ID: 19609473
[TBL] [Abstract][Full Text] [Related]
6. Ablative non-sequential fractional ultrapulsed CO
Huth S; Marquardt Y; Amann PM; Leverkus M; Huth L; Baron JM; Gerber PA
Exp Dermatol; 2016 Dec; 25(12):997-999. PubMed ID: 27194644
[No Abstract] [Full Text] [Related]
7. Effective photodynamic therapy of actinic keratoses and Bowen's disease using microneedle perforation.
Kolde G; Rowe E; Meffert H
Br J Dermatol; 2013 Feb; 168(2):450-2. PubMed ID: 22804095
[No Abstract] [Full Text] [Related]
8. Daylight photodynamic therapy with methyl aminolevulinate for the treatment of actinic keratoses of the forearms.
Fai D; Fai C; Cassano N; Vena GA
G Ital Dermatol Venereol; 2019 Oct; 154(5):603-605. PubMed ID: 29485253
[No Abstract] [Full Text] [Related]
9. Long-term Outcome of Daylight Photodynamic Therapy with Amino-5-laevulinate Nanoemulsion vs. Methyl-5-aminolaevulinate for Actinic Keratoses.
Neittaanmäki-Perttu N; Grönroos M; Tani T; Snellman E
Acta Derm Venereol; 2016 Jun; 96(5):712-3. PubMed ID: 26806126
[No Abstract] [Full Text] [Related]
10. Short incubation photodynamic therapy with methylaminolevulinate and no occlusion for the treatment of actinic keratoses.
Bissonnette R; Bolduc C; Maari C; Nigen S
J Am Acad Dermatol; 2012 Dec; 67(6):1386-7. PubMed ID: 23158619
[No Abstract] [Full Text] [Related]
11. Photodynamic therapy for actinic keratoses: aren't we there yet?
Lui H
JAMA Dermatol; 2014 Dec; 150(12):1289. PubMed ID: 25162746
[No Abstract] [Full Text] [Related]
12. Photodynamic therapy effective for the treatment of actinic keratosis and basal cell carcinoma in bullous pemphigoid patients.
Canavan TN; de la Feld SF; Huang C; Sami N
Photodiagnosis Photodyn Ther; 2017 Jun; 18():257-259. PubMed ID: 28373119
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative photodynamic therapy: a description of a new adjuvant technique for patients with nonmelanoma skin cancer.
Marmur ES; Nolan KA; Henry M
Dermatol Surg; 2012 Jul; 38(7 Pt 1):1073-6. PubMed ID: 22607107
[No Abstract] [Full Text] [Related]
14. Comparative study of trichloroacetic acid vs. photodynamic therapy with topical 5-aminolevulinic acid for actinic keratosis of the scalp.
Di Nuzzo S; Cortelazzi C; Boccaletti V; Zucchi A; Conti ML; Montanari P; Feliciani C; Fabrizi G; Pagliarello C
Photodermatol Photoimmunol Photomed; 2015 Sep; 31(5):233-8. PubMed ID: 25660106
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and safety of daylight photodynamic therapy with methyl amninolevulinate for actinic keratosis of the face and scalp.
Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
Eur J Dermatol; 2017 Feb; 27(1):89-91. PubMed ID: 27748261
[No Abstract] [Full Text] [Related]
16. Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma.
Annemans L; Caekelbergh K; Roelandts R; Boonen H; Leys C; Nikkels AF; van Den Haute V; van Quickenborne L; Verhaeghe E; Leroy B
Eur J Dermatol; 2008; 18(5):539-46. PubMed ID: 18693157
[TBL] [Abstract][Full Text] [Related]
17. Long-term Outcome of Low-concentration Hexyl-5-aminolaevulinate Daylight Photodynamic Therapy for Treatment of Actinic Keratoses.
Neittaanmäki-Perttu N; Karppinen TT; Tani T; Snellman E; Grönroos M
Acta Derm Venereol; 2017 Jan; 97(1):120-121. PubMed ID: 27304514
[No Abstract] [Full Text] [Related]
18. Sequential methyl-aminolevulinate daylight photodynamic therapy and diclofenac plus hyaluronic acid gel treatment for multiple actinic keratosis evaluation.
Cantisani C; Paolino G; Scarnò M; Didona D; Tallarico M; Moliterni E; Losco L; Cantoresi F; Mercuri SR; Bottoniτ U; Calvieri S
Dermatol Ther; 2018 Nov; 31(6):e12710. PubMed ID: 30253027
[No Abstract] [Full Text] [Related]
19. [Distal onycholysis resolved with photodynamic therapy in an elderly patient on multiple medication].
Aspiroz C; Gilaberte Y; Paz-Cristóbal P; Rezusta A
Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):626-8. PubMed ID: 21470716
[No Abstract] [Full Text] [Related]
20. Spanish-Portuguese consensus statement on use of daylight-mediated photodynamic therapy with methyl aminolevulinate in the treatment of actinic keratosis.
Gilaberte Y; Aguilar M; Almagro M; Correia O; Guillén C; Harto A; Pérez-García B; Pérez-Pérez L; Redondo P; Sánchez-Carpintero I; Serra-Guillén C; Valladares LM
Actas Dermosifiliogr; 2015 Oct; 106(8):623-31. PubMed ID: 26115793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
